Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy

European Journal of Clinical Pharmacology
Kazuyuki InoueKunihiko Itoh

Abstract

Lamotrigine (LTG) is used to treat epilepsy. The variability of LTG pharmacokinetics among individuals may be attributed to polymorphisms in the genes of uridine diphosphate glucuronosyltransferases (UGTs) 1A4 and UGT2B7 and/or combination with other drugs. In this study, we evaluated the association between LTG concentrations and patient characteristics such as genetic polymorphisms and the co-administration of antiepileptic drugs. We recruited 122 patients with epilepsy. LTG concentrations were measured in blood samples from each patient under steady-state condition. We assessed the influence of multiple factors on LTG concentrations and derived a formula for predicting LTG concentrations using multiple linear regression analysis. We derived a formula to predict LTG concentrations that considers the daily dose of LTG, body weight, valproic acid concentration, phenytoin co-administration, and the co-administration of phenobarbital and/or carbamazepine as well as UGT1A4 142T>G and UGT2B7 -161C>T polymorphisms (adjusted coefficients of determination R (2) = 0.734). Furthermore, we used this formula to reveal a strong positive correlation between measured and predicted LTG concentrations (r (2) = 0.76, p < 0.001). We derived a fo...Continue Reading

References

Nov 1, 1987·Clinical Pharmacology and Therapeutics·A F CohenA W Peck
Jul 1, 1993·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·G M Shenfield
Jun 2, 1998·The Annals of Pharmacotherapy·G D Anderson
Dec 23, 1998·British Journal of Clinical Pharmacology·R G MorrisB C Sallustio
Oct 24, 2001·Epilepsy Research·A SabersE L Hansen
Mar 22, 2003·Acta Anaesthesiologica Scandinavica·H PleymO Dale
May 27, 2003·Therapeutic Drug Monitoring·Svein I JohannessenPhilip N Patsalos
Dec 4, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Hugo M NeelsWilly E Lambert
Apr 28, 2005·Drug Metabolism and Pharmacokinetics·Mayumi SaekiJun-ichi Sawada
Jul 14, 2005·Journal of Clinical Psychopharmacology·Arne ReimersOlav Spigset
Feb 21, 2006·British Journal of Clinical Pharmacology·Emilio Perucca
Mar 28, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Andrew RowlandJohn O Miners
Oct 20, 2006·Clinical Pharmacokinetics·Svein I Johannessen, Torbjörn Tomson
Jun 9, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Shogo J Miyagi, Abby C Collier
Jan 9, 2008·Seizure : the Journal of the British Epilepsy Association·Marianne Søndergaard KhinchiPeter Wolf
Jun 28, 2008·Seizure : the Journal of the British Epilepsy Association·Claus ReinsbergerGünter Krämer
Dec 18, 2008·Pharmacoepidemiology and Drug Safety·Arne Reimers
Feb 12, 2009·Therapeutics and Clinical Risk Management·Mary Ann Werz
Dec 22, 2009·Expert Review of Neurotherapeutics·Cecilie Johannessen Landmark, Philip N Patsalos
May 24, 2011·Epilepsy Research·Medine Idrizoglu GulcebiFiliz Yılmaz Onat
Apr 3, 2012·Biological & Pharmaceutical Bulletin·Yoshiaki YamamotoYoshiyuki Kagawa
Dec 25, 2012·European Journal of Clinical Pharmacology·Noppaket SingkhamBaralee Punyawudho
Sep 3, 2013·Epilepsy & Behavior : E&B·Ilse WegnerDick Lindhout
Jun 6, 2014·The Lancet. Diabetes & Endocrinology·Rosa Maria ParagliolaRoberto Salvatori
Oct 15, 2014·Acta Neurologica Scandinavica·M KvernelandK O Nakken
Dec 6, 2014·Therapeutic Drug Monitoring·Girish S NaikDenise H Fleming
Dec 11, 2014·European Journal of Drug Metabolism and Pharmacokinetics·Arne ReimersEylert Brodtkorb
Dec 18, 2014·Epileptic Disorders : International Epilepsy Journal with Videotape·Gaetano Zaccara, Emilio Perucca
Apr 30, 2015·Drug Metabolism and Pharmacokinetics·Qiuning WangYingjie Guo

❮ Previous
Next ❯

Citations

Jan 4, 2019·Neuropsychopharmacology Reports·Shogo ItabashiKiyoyuki Kitaichi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.